BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 19389029)

  • 1. Analysis of transfusion reactions associated with prestorage-pooled platelet components.
    Tormey CA; Sweeney JD; Champion MH; Pisciotto PT; Snyder EL; Wu Y
    Transfusion; 2009 Jun; 49(6):1242-7. PubMed ID: 19389029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets.
    Wang RR; Triulzi DJ; Qu L
    Am J Clin Pathol; 2012 Aug; 138(2):255-9. PubMed ID: 22904138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment.
    Osselaer JC; Messe N; Hervig T; Bueno J; Castro E; Espinosa A; Accorsi P; Junge K; Jacquet M; Flament J; Corash L
    Transfusion; 2008 Jun; 48(6):1061-71. PubMed ID: 18346019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment.
    Osselaer JC; Cazenave JP; Lambermont M; Garraud O; Hidajat M; Barbolla L; Tardivel R; Defoin L; Waller C; Mendel I; Raidot JP; Kandel G; De Meuter R; Fabrigli P; Dehenau D; Arroyo JL; Padrón F; Gouezec H; Corral M; Jacquet M; Sundin D; Lin L; Corash L
    Vox Sang; 2008 May; 94(4):315-23. PubMed ID: 18248574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions.
    Blumberg N; Gettings KF; Turner C; Heal JM; Phipps RP
    Transfusion; 2006 Oct; 46(10):1813-21. PubMed ID: 17002639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions.
    Pruss A; Kalus U; Radtke H; Koscielny J; Baumann-Baretti B; Balzer D; Dörner T; Salama A; Kiesewetter H
    Transfus Apher Sci; 2004 Feb; 30(1):41-6. PubMed ID: 14746820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006).
    Eder AF; Kennedy JM; Dy BA; Notari EP; Weiss JW; Fang CT; Wagner S; Dodd RY; Benjamin RJ;
    Transfusion; 2007 Jul; 47(7):1134-42. PubMed ID: 17581147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion.
    Rasonglès P; Angelini-Tibert MF; Simon P; Currie C; Isola H; Kientz D; Slaedts M; Jacquet M; Sundin D; Lin L; Corash L; Cazenave JP
    Transfusion; 2009 Jun; 49(6):1083-91. PubMed ID: 19309473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of double- and triple-apheresis platelet product donation on apheresis donor platelet and white blood cell counts.
    Richa E; Krueger P; Burgstaler EA; Bryant SC; Winters JL
    Transfusion; 2008 Jul; 48(7):1325-32. PubMed ID: 18346017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prestorage pooled whole-blood-derived leukoreduced platelets stored for seven days, preserve acceptable quality and do not show evidence of a mixed lymphocyte reaction.
    Sweeney JD; Kouttab NM; Holme S; Kurtis JD; Cheves TA; Nelson EJ
    Transfusion; 2004 Aug; 44(8):1212-9. PubMed ID: 15265126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes.
    Spiess BD; Royston D; Levy JH; Fitch J; Dietrich W; Body S; Murkin J; Nadel A
    Transfusion; 2004 Aug; 44(8):1143-8. PubMed ID: 15265117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective observational study of low thresholds for platelet transfusion in adult dengue patients.
    Thomas L; Kaidomar S; Kerob-Bauchet B; Moravie V; Brouste Y; King JP; Schmitt S; Besnier F; Abel S; Mehdaoui H; Plumelle Y; Najioullah F; Fonteau C; Richard P; Césaire R; Cabié A
    Transfusion; 2009 Jul; 49(7):1400-11. PubMed ID: 19320862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial contamination of whole-blood-derived platelets: the introduction of sample diversion and prestorage pooling with culture testing in the American Red Cross.
    Benjamin RJ; Kline L; Dy BA; Kennedy J; Pisciotto P; Sapatnekar S; Mercado R; Eder AF
    Transfusion; 2008 Nov; 48(11):2348-55. PubMed ID: 18657074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of bacteriologic screening in platelet concentrates.
    te Boekhorst PA; Beckers EA; Vos MC; Vermeij H; van Rhenen DJ
    Transfusion; 2005 Apr; 45(4):514-9. PubMed ID: 15819671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of bacterial contamination in apheresis platelet products: American Red Cross experience, 2004.
    Fang CT; Chambers LA; Kennedy J; Strupp A; Fucci MC; Janas JA; Tang Y; Hapip CA; Lawrence TB; Dodd RY;
    Transfusion; 2005 Dec; 45(12):1845-52. PubMed ID: 16371037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the effectiveness of whole blood-derived platelets stored as a pool: a randomized block noninferiority trial.
    Heddle NM; Cook RJ; Blajchman MA; Barty RL; Sigouin CS; Boye DM; Nelson EJ; Kelton JG
    Transfusion; 2005 Jun; 45(6):896-903. PubMed ID: 15934987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergic transfusion reactions to platelets are more commonly associated with prepooled than apheresis components.
    Xiao W; Tormey CA; Capetillo A; Maitta RW
    Vox Sang; 2013 Nov; 105(4):334-40. PubMed ID: 23802769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of transfusion of prestorage-leukoreduced apheresis platelets.
    Ogawa Y; Wakana M; Tanaka K; Oka K; Aso H; Hayashi M; Seno T; Ishida T; Nomura S; Fukuhara S
    Vox Sang; 1998; 75(2):103-9. PubMed ID: 9784662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of prestorage pooled leukoreduced whole blood-derived platelets stored for up to 7 days.
    Heddle NM; Barty RL; Sigouin CS; Boye DM; Nelson EJ; Blajchman MA; Kelton JG
    Transfusion; 2005 Jun; 45(6):904-10. PubMed ID: 15934988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased platelet aggregation of platelet concentrate during storage recovers in the body after transfusion.
    Miyaji R; Sakai M; Urano H; Nakata K; Sakamoto H; Shirahata A
    Transfusion; 2004 Jun; 44(6):891-9. PubMed ID: 15157257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.